88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Quasar Medical Unveils New Global Headquarters in Singapore This move strategically enhances Quasar's ties to Singapore's MedTech ecosystem and facilitates closer collaboration with global partners ... 2025-07-29T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress PRINCETON, N.J. and TOKYO , July 29, 2025 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET IGNITE trial of rocatinlimab, an investigational therapy ... 2025-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Leo Cancer Care Receives FDA 510(k) Clearance for Marie® - A Revolutionary Upright Radiotherapy Platform MIDDLETON, Wis. , July 29, 2025 /PRNewswire/ -- Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance ... 2025-07-29T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Fapon to Debut Shine mT8000 Open-Access, High Throughput Clinical Chemistry and Immunoassay Analyzer at ADLM 2025 CHICAGO , July 29, 2025 /PRNewswire/ -- Fapon, a global leading life sciences company, will debut its Shine mT8000 Fully Automated Clinical Chemistry and Immunoassay System at the ADLM 2025 ... 2025-07-29T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats. Finished building will be one ... 2025-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ SUZHOU, China , July 29, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation ... 2025-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: U.S. POINTER STUDY SHOWS STRUCTURED LIFESTYLE PROGRAM TARGETING MULTIPLE RISK FACTORS IMPROVES COGNITION IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE Key Takeaways ... 2025-07-29T Health Care/Hospital Medical/Pharmaceuticals
XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury SUZHOU, China , July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/ Shanghai ) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US ... 2025-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Big Lake Capital, LLC, Led and Controlled by NMHI CEO, Converts $671,984 Note into Nature's Miracle ("NMHI") Common Stocks ONTARIO, Calif. , July 28, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology announce that ... 2025-07-28T Agriculture Banking/Financial Service Medical/Pharmaceuticals
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC) Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting ... 2025-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Trade show news

PR Newswire Asia's news > Medical/Pharmaceuticals